As of Mar 27
| +0.87 / +1.94%|
The 13 analysts offering 12-month price forecasts for Impax Laboratories Inc have a median target of 41.00, with a high estimate of 49.00 and a low estimate of 27.00. The median estimate represents a -10.36% decrease from the last price of 45.74.
The current consensus among 14 polled investment analysts is to Hold stock in Impax Laboratories Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.